Abstract |
Surgery is the only curative strategy for gastric cancer management and radical resection with free margins and extended lymphadenectomy seems to be the best option. Morbidity rate is usually associated with surgical treatment in about 24% of patients, and mortality in about 3%. These rates are influenced by tumor staging, patient condition, surgical strategies and surgeon experience. Their management is mostly conservative and outcome is favorable in the majority of cases. Improvement in gastric cancer treatment must consider experienced surgeons and adequate patient selection.
|
Authors | B Zilberstein, J Abbud Ferreira, I Cecconello |
Journal | Minerva gastroenterologica e dietologica
(Minerva Gastroenterol Dietol)
Vol. 57
Issue 1
Pg. 69-74
(Mar 2011)
ISSN: 1121-421X [Print] Italy |
PMID | 21372771
(Publication Type: Journal Article, Review)
|
Topics |
- Brazil
(epidemiology)
- Gastrectomy
(adverse effects)
- Humans
- Lymph Node Excision
- Neoplasm Staging
- Patient Selection
- Postoperative Complications
(mortality, pathology, therapy)
- Prognosis
- Stomach Neoplasms
(mortality, pathology, surgery)
- Survival Rate
- Treatment Outcome
|